In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $26.70 in the prior trading day, Exelixis Inc (NASDAQ: EXEL) closed at $26.30, down -1.50%. In other words, the price has decreased by -$1.50 from its previous closing price. On the day, 1.83 million shares were traded. EXEL stock price reached its highest trading level at $26.82 during the session, while it also had its lowest trading level at $26.23.
Ratios:
Our goal is to gain a better understanding of EXEL by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.49 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 27.03. For the most recent quarter (mrq), Quick Ratio is recorded 4.21 and its Current Ratio is at 4.27. In the meantime, Its Debt-to-Equity ratio is 0.09 whereas as Long-Term Debt/Eq ratio is at 0.09.
On December 19, 2023, BTIG Research started tracking the stock assigning a Buy rating and target price of $27.
On December 15, 2023, Citigroup started tracking the stock assigning a Buy rating and target price of $31.Citigroup initiated its Buy rating on December 15, 2023, with a $31 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 12 ’24 when Aftab Dana sold 20,883 shares for $27.06 per share. The transaction valued at 565,094 led to the insider holds 500,107 shares of the business.
MARIA C FREIRE bought 8,250 shares of EXEL for $219,122 on Aug 14 ’24. On Aug 08 ’24, another insider, POSTE GEORGE, who serves as the Director of the company, sold 33,725 shares for $26.89 each. As a result, the insider received 906,865 and left with 199,020 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EXEL now has a Market Capitalization of 7502127616 and an Enterprise Value of 6698138112. As of this moment, Exelixis’s Price-to-Earnings (P/E) ratio for their current fiscal year is 22.52, and their Forward P/E ratio for the next fiscal year is 17.92. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 2.05. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.72 while its Price-to-Book (P/B) ratio in mrq is 3.54. Its current Enterprise Value per Revenue stands at 3.326 whereas that against EBITDA is 15.6.
Stock Price History:
The Beta on a monthly basis for EXEL is 0.51, which has changed by 0.25238097 over the last 52 weeks, in comparison to a change of 0.24822903 over the same period for the S&P500. Over the past 52 weeks, EXEL has reached a high of $27.53, while it has fallen to a 52-week low of $18.64. The 50-Day Moving Average of the stock is 14.87%, while the 200-Day Moving Average is calculated to be 17.77%.
Shares Statistics:
The stock has traded on average 1.79M shares per day over the past 3-months and 2923660 shares per day over the last 10 days, according to various share statistics. A total of 302.79M shares are outstanding, with a floating share count of 278.08M. Insiders hold about 2.52% of the company’s shares, while institutions hold 87.52% stake in the company. Shares short for EXEL as of 1722384000 were 10163394 with a Short Ratio of 5.67, compared to 1719532800 on 9187474. Therefore, it implies a Short% of Shares Outstanding of 10163394 and a Short% of Float of 4.8.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 12.0 analysts currently analyzing and rating the stock of Exelixis Inc (EXEL).The consensus estimate for the next quarter is $0.33, with high estimates of $0.39 and low estimates of $0.28.
Analysts are recommending an EPS of between $1.75 and $1.49 for the fiscal current year, implying an average EPS of $1.57. EPS for the following year is $1.52, with 14.0 analysts recommending between $1.91 and $1.17.
Revenue Estimates
17 analysts predict $487.16M in revenue for the current quarter. It ranges from a high estimate of $499M to a low estimate of $465.36M. As of the current estimate, Exelixis Inc’s year-ago sales were $473.58MFor the next quarter, 17 analysts are estimating revenue of $499.17M. There is a high estimate of $519.09M for the next quarter, whereas the lowest estimate is $479.69M.
A total of 20 analysts have provided revenue estimates for EXEL’s current fiscal year. The highest revenue estimate was $2.08B, while the lowest revenue estimate was $2.01B, resulting in an average revenue estimate of $2.05B. In the same quarter a year ago, actual revenue was $1.83BBased on 21 analysts’ estimates, the company’s revenue will be $2.07B in the next fiscal year. The high estimate is $2.26B and the low estimate is $1.89B.
